Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remune and vCP1452 in HIV-positive patients on antiretroviral therapy
NCT00005758Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Viral Vectors, Whole Inactivated Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of Remune, ALVAC-HIV in human immunodeficiency virus infection (HIV), sponsored by National Institute of Allergy and Infectious Diseases. Status: completed.
02
Drugs
RemuneALVAC-HIV
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00005758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005758.